COMMUNIQUÉS West-GlobeNewswire

Stemline Therapeutics Reports First Quarter 2019 Financial Results
10/05/2019
Net revenue for ELZONRIS was $5.05 million for the first quarter Conference call and live webcast scheduled for today at 8:00 AM ET NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), [...]
Zomedica Announces Private Placement of Preferred Shares
10/05/2019
ANN ARBOR, Mich., May 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today announced that it [...]
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
10/05/2019
RANCHO CUCAMONGA, Calif., May 10, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President and Bill Peters, CFO, will be presenting at the Bank of America [...]
Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical
10/05/2019
Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously announced distribution of [...]
ASLAN Pharmaceuticals’ Varlitinib Selected by Leading Korean Gastric Cancer Group for Study in Second-Line Gastric Cancer
10/05/2019
- K-MASTER, Korea’s leading precision medicine research group, to conduct phase 1b/2 umbrella study testing varlitinib as a second-line treatment in HER1/HER2 co-expressing advanced or metastatic gastric cancer patients [...]
Virbac : Declaration of the number of shares and voting rights April 2019
10/05/2019
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et droits de vote Avril 2019
10/05/2019
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
Ambu A/S: Ambu appoints new CEO
10/05/2019
Ambu’s board of directors has appointed Juan-José Gonzalez as the new CEO, effective May 15, 2019, to replace Lars Marcher who resigns from his position. Jens Bager, Chairman of the Ambu Board of Directors, comments, “ [...]
GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents
10/05/2019
GENFIT: Ordinary Shareholder’s Meeting of June 13, 2019 – Availability of Preparatory Documents Lille (France), Cambridge (Massachusetts, United States), May 10, 2019 – GENFIT (Nasdaq and Euronext: GNFT) , a late-stage [...]
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à disposition des documents préparatoires
10/05/2019
GENFIT : Assemblée générale ordinaire du 13 juin 2019 – modalités de mise à disposition des documents préparatoires Lille (France), Cambridge (Massachusetts, États-Unis), le 10 mai 2019 – GENFIT (Nasdaq et Euronext: [...]
Bone Therapeutics SA: The preliminary documents for the Annual Ordinary General Shareholder Meeting on 12 June 2019 have been made available
10/05/2019
Regulated information Gosselies, Belgium, 10 May 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale ordinaire du 12 juin 2019
10/05/2019
Information réglementée Gosselies, Belgique, le 10 mai 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Acacia Pharma’s BARHEMSYS Significantly Improves Post-operative Nausea & Vomiting (PONV) in Rescue Treatment of Ambulatory Patients
10/05/2019
New post-hoc subset analysis from positive Phase 3 trial selected as part of the Excellence and Innovation Awards to be presented at SAMBA 2019 Cambridge, UK and Indianapolis, US – 10 May 2019: Acacia Pharma Group plc [...]
Genesis HealthCare Reports Solid First Quarter 2019 Results
10/05/2019
KENNETT SQUARE, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results [...]
Medtronic Enters Into Definitive Agreement to Acquire Titan Spine
09/05/2019
Acquisition Further Accelerates Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions DUBLIN - May 9, 2019 - Medtronic plc (NYSE:MDT), a global leader in medical [...]
Adynxx, Inc. Receives Nasdaq Notice of Delisting or Failure to Satisfy an Initial Listing Rule or Standard
09/05/2019
SAN FRANCISCO, May 09, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq:ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for [...]
Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
09/05/2019
NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Jamieson Wellness Inc. Announces Voting Results from 2019 Annual Meeting of Shareholders
09/05/2019
TORONTO, May 09, 2019 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. (“ Jamieson Wellness ” or the “ Company ”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of [...]
FibroGen Reports First Quarter 2019 Financial Results
09/05/2019
Positive topline results from pooled safety analyses of roxadustat Phase 3 global program Completed one year of treatment in Phase 2 trial evaluating pamrevlumab in treatment of non-ambulatory DMD patients Conference [...]

Pages